ORBUSNEICH MEDICAL (TREASURY) PTE. LTD.

ORBUS NEICH MEDICAL PTE LTD designs, develops and commercializes innovative medical devices for the treatment of vascular disease. The company’s portfolio includes high‑performance balloons, coronary stents and specialty catheters for coronary and peripheral interventions. ORBUS NEICH holds CE, FDA and NMPA approvals for select products and runs clinical trials to support clinical adoption. The company works directly with physician partners to understand clinical needs, delivers patient education, participates in industry events, and maintains global operations with structured compliance and corporate governance. ORBUS NEICH is committed to simplifying complex vascular treatments and improving long‑term quality of life for patients through focused device innovation and strong clinical collaboration.

OrbusNeich is a multinational medical device company specializing in interventional devices for percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Headquartered in Hong Kong, China, our Group sells its products in more than 70 countries and regions worldwide. It is also actively expanding into structural heart disease. With an in-house R&D team boasting over 20 years of product development expertise, our Group has developed world-leading proprietary technologies. Our portfolio includes Sapphire coronary balloons, Scoreflex specialty balloons, JADE peripheral balloons, and COMBO dual-therapy stents, eucaLimus sirolimus-eluting coronary stents, Support C paclitaxel-coated PTCA balloons, VITUS paclitaxel-coated PTA balloons, Teleport microcatheters, EZGuide, and Xtenza guide extension catheters. For more information, please visit the Group’s official website: updated on 8 December 2025)